Large, emerging economies are closing the gap with developed markets on health care spending as a percentage of GDP²

China 5.5% (2009: 3.5%)

W. Europe: 9%-12%

U.S.: 17%

Israel: The Medical Technology Hub

Israel’s proclivity for innovation, its world-class institutions and highly educated workforce have contributed to the country’s rise as a high-tech powerhouse.

Ranked first in medical device patents and second in medical device solutions per capita, Israel has been a source of breakthrough treatments and drugs such as cardiac catheters, Copaxone, PillCam, EarlySense, ReWalk, BabySense, and dozens more. Israel’s exports of life science-related products and services are valued at billions of dollars annually.³

There are approximately 1,400 life science companies operating in Israel,³ in sectors from imaging to drug delivery, to medical and surgical equipment. Nearly 25% of the Office of the Chief Scientist budget was allocated to companies involved in life sciences.4